E-DNA IM or ID delivery prime enhances antibody and T cell responses following recombinant gp120 env boost

Por Hutnick, NA, Karuppiah, M, Pollara, J, Yan, J, Myles, DJ, Broderick, K, Morrow, M, Sardasai, N, Montefiori, D, Barnett, S, Ferrari, G, Weiner, DB
Publicado em 2012

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family

Por Bonsignori, M, Pollara, J, Moody, MA, Kepler, TB, Chen, X, Gurley, TC, Kozink, DM, Marshall, DJ, Whitesides, JF, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Kim, JH, Michael, NL, Montefiori, DC, Liao, H, Ferrari, G, Haynes, BF
Publicado em 2012

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes

Por Pollara, J, Bonsignori, M, Moody, M, Alam, M, Liao, H, Hwang, K, Pickeral, J, Kappes, J, Ochsenbauer, C, Soderberg, K, Gurley, TC, Kozink, DM, Marshall, DJ, Whitesides, JF, Montefiori, D, Robinson, JE, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Kim, J, Michael, N, Tomaras, G, Haynes, BF, Ferrari, G
Publicado em 2012

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

Por Williams, WB, Jones, K, Krambrink, A, Grove, D, Liu, P, Yates, NL, Moody, MA, Ferrari, G, Pollara, J, Moodie, Z, Morgan, CA, Liao, H, Montefiori, DC, Ochsenbauer, C, Kappes, J, Hammer, S, Mascola, J, Koup, R, Corey, L, Nabel, G, Gilbert, P, Churchyard, G, Keefer, M, Graham, BS, Haynes, BF, Tomaras, GD
Publicado em 2012